Evaluation of the drug-drug interaction between low-dose methotrexate and short-term use of non-steroidal anti-inflammatory drugs
In our opinion, no additional safety monitoring is required during short-term NSAID use in patients using LD-MTX in the absence of risk factors. In the presence of risk factors, i.e. renal insufficiency, dosage MTX > 20 mg/week, diabetes mellitus, dehydration, and use of acetylsalicylic acid in analgesic dose, DDI management should be individualized.
Authors
- Merel van Nuland (ORCID: https://orcid.org/0000-0003-1763-7334)
- Tom Jacobs (ORCID: https://orcid.org/0000-0001-5738-5528)
- Madelon Butterhoff
- Paul D van der Linden
- Manon G. den Uil
Institutions
- Radboud University Nijmegen (NL)
- Utrecht University (NL)
- University Medical Center (US)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Tergooi (NL)
Publication Details
- Journal
- Expert Opinion on Drug Metabolism & Toxicology
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1080/17425255.2025.2546127
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00